Human papillomavirus (HPV) DNA and HIV positivity in relation to characteristics of all study participants (n=214)
| Characteristic | Prevalence of characteristic | HPV DNA positive | HIV–1/2 positive | Multiple HPV positive | Circumcised | ||||
| No (%) | No (%) | p Value | No (%) | p Value | No (%) | p Value | No (%) | p Value | |
| HIV* | |||||||||
| Negative | 106/210 (50.5%) | 69 (65.1%) | – | – | 47 (68.1%) | – | – | ||
| Positive | 104/210 (49.5%) | 94 (90.4%) | <0.001 | – | – | 85 (90.4%) | <0.001 | – | – |
| Circumcised† | |||||||||
| No | 154/208 (74.0%) | 125 (81.2%) | 83 (55.0%) | 104 (83.2%) | – | – | |||
| Yes | 54/208 (26.0%) | 35 (64.8%) | 0.014 | 20 (37.7%) | 0.031 | 26 (74.3%) | 0.232 | – | – |
| Patient group | |||||||||
| Anogenital wart participants | 108/214 (50.5%) | 108 (100%) | 76 (71.7%) | 95 (88.0%) | 21 (20.0%) | ||||
| Male urethritis syndrome participants | 56/214 (26.2%) | 27 (48.2%) | 20 (35.7%) | 15 (55.6%) | 13 (23.2%) | ||||
| Voluntary counselling and testing/asymptomatic participants | 50/214 (23.3%) | 31 (62.0%) | <0.001 | 8 (16.7%) | <0.001 | 25 (80.7%) | 0.001 | 20 (42.6%) | 0.012 |
| Age group | |||||||||
| 18–29 | 116/214 (54.2%) | 84 (72.4%) | 38 (33.9%) | 65 (77.4%) | 29 (25.2%) | ||||
| 30–39 | 74/214 (34.6%) | 62 (83.8%) | 50 (67.6%) | 54 (87.1%) | 19 (27.5%) | ||||
| 40+ | 24/214 (11.2%) | 20 (83.3%) | 0.144 | 16 (66.7%) | <0.001 | 16 (80.0%) | 0.326 | 6 (25.0%) | 0.935 |
| Marital status | |||||||||
| Married | 44/214 (20.6%) | 32 (72.7%) | 25 (56.8%) | 27 (84.4%) | 13 (30.2%) | ||||
| Single with girlfriend | 156/214 (72.9%) | 120 (76.9%) | 69 (45.4%) | 95 (79.2%) | 37 (24.5%) | ||||
| Single without girlfriend | 14/214 (6.5%) | 14 (100.0%) | 0.096 | 10 (71.4%) | 0.097 | 13 (92.9%) | 0.409 | 4 (28.6%) | 0.732 |
| Total no of patients | 214/214 (100.0%) | 166/214 (77.6%) | 104/210 (49.5%) | 135/214 (81.3%) | 54/208 (26.0%) | ||||